TScan Therapeutics
TCRX
#9298
Rank
ยฃ52.69 M
Marketcap
ยฃ0.93
Share price
-5.56%
Change (1 day)
-83.98%
Change (1 year)

Revenue for TScan Therapeutics (TCRX)

Revenue in 2024 (TTM): ยฃ2.18 Million

According to TScan Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ2.2 Million. a decrease over the revenue in the year 2023 that were of ยฃ16.52 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for TScan Therapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 ยฃ2.24 M-86.42%
2023 ยฃ16.52 M47.68%
2022 ยฃ11.18 M48.92%
2021 ยฃ7.51 M843.81%
2020 ยฃ0.79 M